• By Adrianne Alexander, RN, BSN, CBC
  • Posted July 17, 2024

Expanding Your High-Risk Breast Program: Best Practices for Growth and Impact

One of the accomplishments I am most proud of is driving the creation of a successful high-risk breast program in a large community-based health system. I am often asked how we did it. For advice on getting started, check out the first blog in this series. If you have already implemented a high-risk breast program, congratulations! It’s time…


  • By Heather Fecteau, MS, CGC
  • Posted May 1, 2024

Putting Patients First: The Ambry CARE Program®'s Commitment to Patient Experience

With 25 years of innovation experience, Ambry has been a leading pioneer in genetic testing. But Ambry prioritizes more than performing testing. Since the launch of the Ambry CARE Program® in 2019, Ambry has also consistently helped to improve the delivery of genetic services. Why CARE? We know significant gaps exist between medical guidelines…


  • By Liese Vito, MD
  • Posted February 7, 2024

CARE Patient Examples at Lake Health

Many patients are anxious about their family history—more than providers realize. In some cases, they may feel like a ticking time bomb with no options. In Part One of this blog series, I talked about The Ambry CARE ProgramTM and how Lake Health has been able to use it to identify more high-risk patients, increase family history and cancer risk…


  • By Meagan Farmer
  • Posted October 18, 2023

Breast Cancer Awareness Month: CHEK2 with Petra Kleiblova and Zdenek Kleibl

Amby Genetics is proud to have worked with a large international team on clarifying the significance of CHEK2 variants. We connected with team leaders Dr. Petra Kleiblova and Dr. Zdenek Kleibl ahead of Breast Cancer Awareness Month. They provided us with the following commentary on the importance of the recent publication, “ENIGMA CHEK2gether…


  • By Meagan Farmer
  • Posted September 27, 2023

Ambry Spotlight: BRCAResponder Amy Byer Shainman

Amy Byer Shainman, also known as BRCAResponder, is a patient advocate, author, and producer who provides support and education related to having a pathogenic variant in BRCA1/2 or other cancer predisposition genes. We connected with her ahead of National Previvor Day and Hereditary Breast and Ovarian Cancer Week. Amy’s sister was diagnosed…


  • By Jodi Tahsler
  • Posted June 14, 2023

Passing on a Legacy of Health: Ben Huebsch Shares His BRCA Story for Men’s Health Week

Ben Huebsch was inspired to become an educator because of his mother’s advice to give back to his community. He loves his job as a middle school principal: he gets a front-row seat to the impact a dedicated staff can have on young lives! He is continuing his mother’s legacy by sharing his firsthand experience with BRCA testing for…


  • By Jodi Tahsler
  • Posted June 13, 2023

Outlier: Runi Limary Let Her Voice Be Heard on BRCA Gene Patents

When it comes to breast cancer, Runi Limary has more personal experience than average. She not only spent time working at a nonprofit for people with breast cancer, but she was diagnosed herself at the young age of twenty-eight. When ACLU lawyers reached out to her about the court case regarding BRCA1 and BRCA2 patents to see…


  • By Jodi Tahsler
  • Posted November 10, 2022

A Q&A with My Faulty Gene founder Kathy Baker

My Faulty Gene is a nonprofit organization that provides information and assistance to individuals whose family medical history suggests genetic testing might be helpful in identifying an increased risk of disease due to a genetic mutation. They believe that everyone in need of genetic testing should have access to it. We sat down with Kathy


  • By Emily Huebsch
  • Posted September 27, 2022

A Different Kind of Patient: Emily Huebsch Empowers Herself and Others Against Breast Cancer

Previvor: A person who has not been diagnosed with cancer, but has survived the predisposition, or higher risk, due to certain genetic mutations.* Breast cancer. Spoken in hushed tones, these scary words are often compounded by the aftermath of breast cancer deaths, creating a stigma around discussing breast cancer in regular conversations. With…


  • By Carrie Horton, MS, CGC
  • Posted October 3, 2018

Science In 60: Looking Beyond BRCA 1/2 to Identify Women at Risk for Breast Cancer

The adoption of multi-gene panel testing (MGPT) has been a game changer in the hereditary breast cancer arena. As evidence surrounding the growing number of breast cancer predisposition genes has accumulated, ATM, CHEK2, and PALB2 have stood out and become undisputed susceptibility genes conferring a moderate risk for…